INVE-A Stock Analysis: Investor ser. | ST
Asset Management | ST, Sweden | Market Cap: 1.213.771m SEK | 12M Return: 33.5% | SE0015811955 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 140M
EPS Trend: 0.0%
Rev. Trend: 5.5%
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Investor AB (publ), listed on the Stockholm Stock Exchange under ticker INVE-A, is a Swedish publicly traded investment company founded in 1916 and headquartered in Stockholm. Structured as a holding company under Swedish corporate law, it is classified under the GICS Industrials sector despite operating primarily as a private equity and investment vehicle. The firm is historically associated with the Wallenberg family, one of Swedens most prominent industrial dynasties, and ranks among the largest listed investment companies in the Nordic region.
The firm specializes in mature, middle-market buyouts and growth capital investments, with core investments spanning healthcare, financial services, IT and fintech, life sciences, materials science, AI, and quantum technology. It targets leading minority positions in listed companies and seeks global deployment opportunities, with operating investments focused on medium-sized to large companies headquartered in Northern Europe.
Investor AB typically deploys between $200 million and $700 million per transaction, considering both majority and minority stakes in listed and unlisted companies. It generally holds investments for a 3-7 year horizon, seeks board representation in portfolio companies, and distinguishes between long-term operating investments and shorter-horizon financial holdings.
- Atlas Copco and ABB earnings lift fair value of listed holdings
- Dividend payout and buybacks support total shareholder returns
- Unlisted investments gain traction in healthcare and industrial tech
| Net Income: 263b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -0.34 > 1.0 |
| NWC/Revenue: 7.72% < 20% (prev 45.94%; Δ -38.22% < -1%) |
| CFO/TA 0.02 > 3% & CFO 23.9b > Net Income 263b |
| Net Debt (106b) to EBITDA (267b): 0.40 < 3 |
| Current Ratio: 2.21 > 1.5 & < 3 |
| Outstanding Shares: last quarter (3.07b) vs 12m ago 0.03% < -2% |
| Gross Margin: 93.46% > 18% (prev 91.69%; Δ 1.77% > 0.5%) |
| Asset Turnover: 27.58% > 50% (prev 8.76%; Δ 18.82% > 0%) |
| Interest Coverage Ratio: 48.85 > 6 (EBIT TTM 267b / Interest Expense TTM 5.46b) |
| A: 0.02 (Total Current Assets 43.5b - Total Current Liabilities 19.7b) / Total Assets 1249b |
| B: 0.74 (Retained Earnings 925b / Total Assets 1249b) |
| C: 0.24 (EBIT TTM 267b / Avg Total Assets 1117b) |
| D: 6.65 (Book Value of Equity 1086b / Total Liabilities 163b) |
| Altman-Z'' = 11.13 = AAA |
| DSRI: 3.0 (Receivables 12.5b/3.00m, Revenue 308b/86.3b) |
| GMI: 0.98 (GM 91.69% / 93.46%) |
| AQI: 1.03 (AQ_t 0.95 / AQ_t-1 0.92) |
| SGI: 3.57 (Revenue 308b / 86.3b) |
| TATA: 0.19 (NI 263b - CFO 23.9b) / TA 1249b) |
| Beneish M = 0.48 (Cap -4..+1) = D |
As of October 07, 2026, the stock is trading at SEK 403.10 with a total of 336,121 shares traded. Over the past week, the price has changed by +0.67%, over one month by +0.25%, over three months by +1.36% and over the past year by +33.49%.
Current recommended Stop Loss: 395.90 (which is 1.8% or 1.4 ATR below the current price).
Investor ser. has no consensus analysts rating.
P/E Trailing = 4.6231
P/E Forward = 3.6711
P/S = 3.7003
P/B = 1.1342
P/EG = 4.9117
Revenue TTM = 308b SEK
EBIT TTM = 267b SEK
EBITDA TTM = 267b SEK
Long Term Debt = 111b SEK (from longTermDebt, last fiscal year)
Short Term Debt = 1.45b SEK (from shortTermDebt, last quarter)
Debt = 126b SEK (from shortLongTermDebtTotal, last quarter) + Leases 128.0m
Net Debt = 106b SEK (calculated: Debt 126b - CCE 19.5b)
Enterprise Value = 1320b SEK (1214b + Debt 126b - CCE 19.5b)
Interest Coverage Ratio = 48.85 (Ebit TTM 267b / Interest Expense TTM 5.46b)
EV/FCF = 63.82x (Enterprise Value 1320b / FCF TTM 20.7b)
FCF Yield = 1.57% (FCF TTM 20.7b / Enterprise Value 1320b)
FCF Margin = 6.71% (FCF TTM 20.7b / Revenue TTM 308b)
Net Margin = 85.22% (Net Income TTM 263b / Revenue TTM 308b)
Gross Margin = 93.46% ((Revenue TTM 308b - Cost of Revenue TTM 20.2b) / Revenue TTM)
Gross Margin QoQ = none% (prev 67.33%)
Tobins Q-Ratio = 1.06 (Enterprise Value 1320b / Total Assets 1249b)
Interest Expense / Debt = 4.33% (Interest Expense 5.46b / Debt 126b)
Taxrate = 0.46% (1.22b / 264b)
NOPAT = 265b (EBIT 267b * (1 - 0.46%))
Current Ratio = 2.21 (Total Current Assets 43.5b / Total Current Liabilities 19.7b)
Debt / Equity = 0.12 (Debt 126b / totalStockholderEquity, last quarter 1086b)
Debt / EBITDA = 0.40 (Net Debt 106b / EBITDA 267b)
Debt / FCF = 5.15 (Net Debt 106b / FCF TTM 20.7b)
Total Stockholder Equity = 981b (last 4 quarters mean from totalStockholderEquity)
RoA = 23.51% (Net Income 263b / Total Assets 1249b)
RoE = 26.77% (Net Income TTM 263b / Total Stockholder Equity 981b)
RoCE = 24.42% (EBIT 267b / Capital Employed (Equity 981b + L.T.Debt 111b))
RoIC = 21.84% (NOPAT 265b / Invested Capital 1216b)
WACC = 7.49% (E(1214b)/V(1340b) * Re(7.82%) + D(126b)/V(1340b) * Rd(4.33%) * (1-Tc(0.00)))
Discount Rate = 7.82% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 46.81 | Cagr: 0.01%
[DCF] Terminal Value 76.09% ; FCFF base≈20.3b ; Y1≈21.2b ; Y5≈24.4b
[DCF] Fair Price = 216.9 (EV 377b - Net Debt 106b = Equity 270b / Shares 1.25b; r=8.35% [WACC [floored]]; 5y FCF grow 5.12% → 2.50% )
EPS Correlation: 0.02 | EPS CAGR: 0.02% | SUE: N/A | # QB: 0
Revenue Correlation: 5.49 | Revenue CAGR: 2.33% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=0.00 | Chg30d=N/A | Revisions=N/A | GrowthEPS=+0.0% | GrowthRev=+5.1%
EPS next Year (2027-12-31): EPS=0.00 | Chg30d=N/A | Revisions=N/A | GrowthEPS=+0.0% | GrowthRev=+0.5%